Recent Press Releases

Charles River's Early Drug Discovery Collaboration with AstraZeneca Delivers Respiratory Candidate Drug

WILMINGTON, Mass.--Charles River Laboratories International, Inc. announced today that its integrated drug discovery collaboration with AstraZeneca has delivered an oral respiratory candidate drug...

BioPharma Services Inc. Announces the Grand Opening of Its Clinical Operations in the US

TORONTO--BioPharma Services Inc. (BPSI), a full service clinical research organization (CRO), announces the grand opening of its new 48-bed Phase 1 Clinical Facility in Columbia, Missouri which is...

genae Opens Offices in New York City

ANTWERP, Belgium and NEW YORK -- genae, a global Contract Research Organization (CRO) and service provider for the medical industries, announced today the expansion of its North American activities...

Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

ROCKVILLE, Md. -- Accelovance, Inc. (Accelovance), a contract research organization (CRO) focusing in early phase oncology, vaccines, and general medicine, today announced that Dr. Joseph D. Purvis...

Chiltern acquires Pacific Clinical Research Pte Limited and expands operations and therapeutic depth in Asia-Pacific

LONDON and WILMINGTON, N.C. -- Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific...

Catalent Expands Its Technology Offerings in Biologics, Acquires Redwood Bioscience Inc. and the SMARTagT Technology Platform

SOMERSET, N.J. -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today...

WuXi PharmaTech Laboratory Testing Division Expands in U.S. With Acquisition of XenoBiotic Laboratories, Inc.

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (WuXi) (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the...

PAREXEL International Announces Acquisition of ClinIntel, Extending Leadership in Randomization and Trial Supply Management

Boston, MA – PAREXEL International Corporation (Nasdaq: PRXL)("PAREXEL" or the "Company"), a global clinical research organization, announced today that the Company has...

Update on Co-Development Partnerships

Good progress with partnerships and additional clinical studies commenced Guildford, UK: Ergomed plc, (LSE: ERGO) a profitable UK-based company dedicated to the provision of specialised services to...

Evotec and its partners awarded public grants to develop new drug candidates to treat multiple sclerosis

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that it has entered into three novel research projects for the treatment of Multiple Sclerosis...

Catalent And Cingulate Therapeutics Sign Exclusive Agreement For Development Of New ADHD Treatments

Somerset, N.J. — Catalent Pharma Solutions has reached an exclusive development and licensing agreement with privately held biopharmaceutical company, Cingulate Therapeutics (CTx), to support...

PPD Exercises Option to Acquire Remaining Interest in X-Chem, Inc.

WILMINGTON, N.C. & WALTHAM, Mass.--Pharmaceutical Product Development, LLC (PPD) and X-Chem, Inc. announced today that PPD has exercised its option to acquire the remaining minority ownership...

ICON Plc Announces Completion of $40 Million Share Buyback and a Further Share Buyback Program for up to $100 Million

DUBLIN--ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40...

New OptiPact™ Technology Introduced By Catalent

Somerset, N.J.— Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has...

FlowMetric, Inc., Forms New Affiliate Company, FlowMetric Diagnostics Inc. to Develop Advanced Diagnostics from Flow Cytometry Platform

DOYLESTOWN, Pa.--FlowMetric, Inc., a leader in flow cytometry and cell sorting services, announced today the formation of its new affiliate company FlowMetric Diagnostics Inc. for the express purpose...

ACRO SURVEY SHOWS STRONG GROWTH OF CRO INDUSTRY

Members boast 100,000 employees, conduct clinical trials in 142 countries WASHINGTON, DC – Members of the Association of Clinical Research Organizations (ACRO) have more than doubled in size in...

PCI Announces Acquisition Of Biotec

PHILADELPHIA, Sept. 19, 2014 /PRNewswire/ -- PCI is pleased to announce it has acquired Biotec Services International (Biotec). Biotec is a leading provider of Clinical Trial Services and...

Covance and Frenova Renal Research Establish Innovative Research Collaboration

Researchers Will Share and Analyze Data to Improve Lives of Patients Living With Chronic Kidney Disease and End Stage Renal Disease Princeton, N.J., and Waltham, Mass., September 17, 2014 —...

PAREXEL Expands Industry-Leading Perceptive® Partner Program with Addition of CRF Health and Clinical Ink

Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative BOSTON, MA – PAREXEL...